42
References
1. Eitzen EM Jr, Takafuji ET (1997) Historical overview of biological warfare. In: Sidell FR,
Takafuji ET, Franz DR (eds) Medical aspects of chemical and biological warfare. Office of
the Surgeon General, Borden Institute, Walter Reed Army Medical Center, Washington, DC,
pp 415–423
2. Ridel R (2004) Biological warfare and bioterrorism: a historical review. Proc Bayl Univ Med
Cent 17(4):400–406
3. WHO (2003) Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 78. 86.92
4. Gray C (2007) Another bloody century: future warfare, Phoenix, pp 265–266
5. Heymann DL (2001) Strengthening global preparedness for defense against infectious disease
threats. Committee on Foreign Relations, United States Senate. Hearing on the threat of bioterrorism and the Spread of Infectious Diseases
6. Hoffman RE, Norton JE (2000) Lessons learned from a full-scale bioterrorism exercise. Emerg
Infect Dis 6:652–653
Fig. 2.23 SPR sensor response for the interaction of different concentration of BoNT/A antigen
with (a) immobilized BoNT/A antibody (a) 0.225 fM, (b) 0.45 fM, (c) 2.25 fM and (d) 4.5 fM (b)
immobilized SV (a) 0.045 fM, (b) 0.225 fM, (c) 1.12 fM and (d) 5.62 fM Temperature: 25o C and
pH: 7.5 [84]
J. H. Banoub and A. Mikhael
References
1. Eitzen EM Jr, Takafuji ET (1997) Historical overview of biological warfare. In: Sidell FR,
Takafuji ET, Franz DR (eds) Medical aspects of chemical and biological warfare. Office of
the Surgeon General, Borden Institute, Walter Reed Army Medical Center, Washington, DC,
pp 415–423
2. Ridel R (2004) Biological warfare and bioterrorism: a historical review. Proc Bayl Univ Med
Cent 17(4):400–406
3. WHO (2003) Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 78. 86.92
4. Gray C (2007) Another bloody century: future warfare, Phoenix, pp 265–266
5. Heymann DL (2001) Strengthening global preparedness for defense against infectious disease
threats. Committee on Foreign Relations, United States Senate. Hearing on the threat of bioterrorism and the Spread of Infectious Diseases
6. Hoffman RE, Norton JE (2000) Lessons learned from a full-scale bioterrorism exercise. Emerg
Infect Dis 6:652–653
Fig. 2.23 SPR sensor response for the interaction of different concentration of BoNT/A antigen
with (a) immobilized BoNT/A antibody (a) 0.225 fM, (b) 0.45 fM, (c) 2.25 fM and (d) 4.5 fM (b)
immobilized SV (a) 0.045 fM, (b) 0.225 fM, (c) 1.12 fM and (d) 5.62 fM Temperature: 25o C and
pH: 7.5 [84]
J. H. Banoub and A. Mikhael